Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 48433-009

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 48433-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safecor Health, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Unit Carton (Export 00)

FDA Label Image

Atorvastatin Calcium Tablets, Usp 80 mg Unit Carton Label (Export 01)

FDA Label Image

Atorvastatin Calcium Structural Formula (Image 01)

FDA Label Image

Atorvastatin Calcium Tablets, Usp 10 mg Unit Carton Label (Image 02)

FDA Label Image

Atorvastatin Calcium Tablets, Usp 10 mg Unit Carton Label (Image 03)

FDA Label Image

Atorvastatin Calcium Tablets, Usp 40 mg Unit Carton Label (Image 04)

This is a description of Atorvastatin Calcium tablets in a package containing 100 tablets (10x10). The NDC number for the product is 48433-009-20. The instructions on the package likely include dosage guidance and storage instructions.*

FDA Label Image

Figure 1: Effect Of Atorvastatin Calcium Tablets 10 mg/day On Cumulative Incidence Of Non-fatal Myocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (Image 06)

This text provides information on cumulative incidence (%) and hazard ratio (HR=0.64, 95% CI 0.50-0.83) over a period of 35 years. The data is presented in a graphical format showing the cumulative incidence percentages over time.*

FDA Label Image

Figure 2: Effect Of Atorvastatin Calcium Tablets 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or (Image 07)

This text provides information on the cumulative hazard at 15%, hazard ratio of 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. It also mentions the time to the first primary endpoint through four years of follow-up.*

FDA Label Image

Figure 3: Effect Of Atorvastatin Calcium Tablets 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (Image 08)

This text provides data on the percentage of subjects experiencing an event for two different dosages of Atorvastatin (10 mg and 80 mg) over time, along with hazard ratio (HR) values and p-values. It also presents information on the time to the first major cardiovascular endpoint in years.*

FDA Label Image

Unit Carton (Image 09)

This description is not available.*

FDA Label Image

Unit Carton (Image 10)

This description is not available.*

FDA Label Image

Unit Carton (Image 11)

This is a description of a packaging label for a product distributed by Safecor Health Company. The packaging is described as not being child-resistant. The container is intended for institutional use only. It emphasizes keeping all drugs out of reach of children and mentions high resistance. Additionally, the packaging lacks a window for lot number and expiration date. Contact information for Safecor Health is provided, including their phone number and website.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.